Cite

HARVARD Citation

    Henon, C. et al. (2019). Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor. Annals of oncology. pp. 1401-1403. [Online]. 
  
Back to record